Cambridge Health Group, the wholly owned subsidiary of Dubai Financial Market-listed investor Amanat (AMANAT), has acquired Cornerstone Healthcare, a UK provider of specialist complex care, in a deal worth up to £76 million. The purchase extends the Dubai-based group into the UK market and lifts its capacity beyond 1,000 beds.

Cornerstone operates four specialist care homes with 283 beds across the south of England, caring for people with complex dementia, neuro-progressive conditions, severe mental illness, acquired brain injury and neurorehabilitation needs.

The home count includes The Burren, a 78-bed home in Bristol opened in 2025, and revenue from its existing homes has grown at a compound annual rate of close to 10 percent over the past three years. Cornerstone is expected to generate approximately £36 million of revenue and £7 million of EBITDA in the 2027 calendar year.

The seller was UK private equity investor Ignite Growth, and Cornerstone’s management team, led by chief executive Paul Hayes, will continue to run the business.

For Amanat, the deal takes completed and committed capital deployment to approximately £184 million, or 60 percent of its £306 million target. It builds on Cambridge Health Group’s established presence in the United Arab Emirates and Saudi Arabia, where the group is expanding Cambridge Hospital in Jeddah and developing a 155-bed hospital in Riyadh.

Cambridge Health Group has set a medium-term target of more than 1,500 beds through further developments and acquisitions.

“Amanat’s strategy is focused on scaling our existing businesses, expanding into complementary areas that offer attractive returns and delivering sustainable value for our shareholders,” said Dr Ali bin Harmal Aldhaheri, chairman of the board of directors.

Aldhaheri added: “By combining Cornerstone’s expertise with Cambridge Health Group’s established operations and growth pipeline in the GCC, we are building a larger, more diversified specialist healthcare business.”

The structural driver is an ageing population and the resulting growth in demand for long-term and specialist care, in a highly fragmented UK market that continues to attract both strategic and private equity buyers. Sector deal activity reached 114 transactions in the first quarter of 2026, up 37 percent year on year.

For the sector, the deal confirms that Gulf-listed healthcare investors are using UK specialist care assets to build international scale beyond their home markets.

Source: business-sale.com / distilledpost.com / khaleejtimes.com / tradingview.com / dealroom.co